Venture cash piling on to beat 1Q total

Biotechnology companies announced another $242.5m in venture capital funding during the week ended Friday, 25 April, keeping the second quarter on track to beat the $1.1bn that biotech firms raised during the first quarter.

More from Alimentary/Metabolic

More from Therapy Areas